{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:52:25Z","timestamp":1791031945943,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,11,17]],"date-time":"2006-11-17T00:00:00Z","timestamp":1163721600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2006,12,19]]},"DOI":"10.1007\/s00213-006-0611-0","type":"journal-article","created":{"date-parts":[[2006,11,16]],"date-time":"2006-11-16T17:32:14Z","timestamp":1163698334000},"page":"241-249","source":"Crossref","is-referenced-by-count":49,"title":["Occupancy of dopamine D1, D2 and serotonin2A receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol"],"prefix":"10.1007","volume":"190","author":[{"given":"M.","family":"Reimold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Solbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Noda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-E.","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Beneke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-J.","family":"Machulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Bares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Wormstall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,11,17]]},"reference":[{"key":"611_CR1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1176\/ajp.155.11.1550","volume":"155","author":"A Abi-Dargham","year":"1998","unstructured":"Abi-Dargham A, Gil R, Krystal J, Baldwin RM, Seibyl JP, Bowers M, van Dyck CH, Charney DS, Innis RB, Laruelle M (1998) Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry 155:761\u2013767","journal-title":"Am J Psychiatry"},{"issue":"9","key":"611_CR2","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1523\/JNEUROSCI.22-09-03708.2002","volume":"22","author":"A Abi-Dargham","year":"2002","unstructured":"Abi-Dargham A, Mawlawi O, Lombardo I, Gil R, Martinez D, Huang Y, Hwang DR, Keilp J, Kochan L, Van Heertum R, Gorman JM, Laruelle M (2002) Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosci 22(9):3708\u20133719","journal-title":"J Neurosci"},{"issue":"4","key":"611_CR3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00004714-199808000-00012","volume":"18","author":"B Andree","year":"1998","unstructured":"Andree B, Nyberg S, Ito H, Ginovart N, Brunner F, Jaquet F, Halldin C, Farde L (1998) Positron emission tomographic analysis of dose-dependent MDL 100,907 binding to 5-hydroxytryptamine-2A receptors in the human brain. J Clin Psychopharmacol 18(4):317\u2013323","journal-title":"J Clin Psychopharmacol"},{"key":"611_CR4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0883-2889(86)90100-0","volume":"37","author":"RF Dannals","year":"1986","unstructured":"Dannals RF, Ravert HT, Wilson AA, Wagner HN Jr (1986) An improved synthesis of (3-N-[11C]methyl)spiperone. Int J Rad Appl Instrum, A Appl Radiat Isot 37:433\u2013434","journal-title":"Int J Rad Appl Instrum, A Appl Radiat Isot"},{"key":"611_CR5","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/jlcr.2580240808","volume":"24","author":"E Ehrin","year":"1987","unstructured":"Ehrin E, Gawell L, H\u00f6gberg T, de Paulis S, Str\u00f6m P (1987) Synthesis of [methoxy-3H]- and [methoxy-11C]-labelled raclopride. Specific dopamine-D2 receptor ligands. J Label Compd Radiopharm 24:931\u2013940","journal-title":"J Label Compd Radiopharm"},{"key":"611_CR6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1192\/S0007125000296888","volume":"17","author":"L Farde","year":"1992","unstructured":"Farde L, Nordstrom AL (1992) PET analysis indicates atypical central dopamine receptor occupancy in clozapine-treated patients. Br J Psychiatry Suppl (17):30\u201333","journal-title":"Br J Psychiatry Suppl"},{"issue":"4735","key":"611_CR7","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1126\/science.2867601","volume":"231","author":"L Farde","year":"1986","unstructured":"Farde L, Hall H, Ehrin E, Sedvall G (1986) Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science 231(4735):258\u2013261","journal-title":"Science"},{"issue":"7","key":"611_CR8","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archpsyc.1992.01820070032005","volume":"49","author":"L Farde","year":"1992","unstructured":"Farde L, Nordstrom AL, Wiesel FA, Pauli S, Halldin C, Sedvall G (1992) Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Arch Gen Psychiatry 49(7):538\u2013544","journal-title":"Arch Gen Psychiatry"},{"key":"611_CR9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1055\/s-2004-832684","volume":"37","author":"WF Gattaz","year":"2004","unstructured":"Gattaz WF, Diehl A, Geuppert MS, Hubrich P, Schmitt A, Linde I, Maras A, Dittmann RW (2004) Olanzapine versus flupenthixol in the treatment of inpatients with schizophrenia: a randomized double-blind trial. Pharmacopsychiatry 37:279\u2013285","journal-title":"Pharmacopsychiatry"},{"key":"611_CR10","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-93700-2","volume-title":"Flupentixol\u2014typisches oder atypisches Wirkspektrum?","author":"T Glaser","year":"1998","unstructured":"Glaser T, Soyka M (1998) Flupentixol\u2014typisches oder atypisches Wirkspektrum? Steinkopff, Darmstadt"},{"issue":"10","key":"611_CR11","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/archpsyc.60.10.974","volume":"60","author":"G Gr\u00fcnder","year":"2003","unstructured":"Gr\u00fcnder G, Carlsson A, Wong DF (2003) Mechanism of new antipsychotic medications: occupancy is not just antagonism. Arch Gen Psychiatry 60(10):974\u2013977","journal-title":"Arch Gen Psychiatry"},{"key":"611_CR12","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0883-2889(86)90044-4","volume":"37","author":"C Halldin","year":"1986","unstructured":"Halldin C, Stone-Elander S, Farde L, Ehrin E, Fasth KJ, L\u00e5ngstr\u00f6m B, Sedvall G (1986) Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography. Int J Rad Appl Instrum, A Appl Radiat Isot 37:1039\u20131043","journal-title":"Int J Rad Appl Instrum, A Appl Radiat Isot"},{"issue":"3","key":"611_CR13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0197-0186(96)00093-9","volume":"30","author":"N Huang","year":"1997","unstructured":"Huang N, Ase AR, Hebert C, van Gelder NM, Reader TA (1997) Effects of chronic neuroleptic treatments on dopamine D1 and D2 receptors: homogenate binding and autoradiographic studies. Neurochem Int 30(3):277\u2013290","journal-title":"Neurochem Int"},{"key":"611_CR14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-3-642-70140-5_2","volume":"2","author":"J Hyttel","year":"1985","unstructured":"Hyttel J, Larsen JJ, Christensen AV, Arnt J (1985) Receptor-binding profiles of neuroleptics. Psychopharmacology Suppl 2:9\u201318","journal-title":"Psychopharmacology Suppl"},{"key":"611_CR15","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1046\/j.1471-4159.2001.00154.x","volume":"76","author":"J Ichikawa","year":"2001","unstructured":"Ichikawa J, Ishii H, Bonaccorso S, Fowler WL, O\u2019Laughlin IA, Meltzer HY (2001) 5-HT2A and D2 receptor blockade increases cortical DA release via 5-HT1A receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release. J Neurochem 76:1521\u20131531","journal-title":"J Neurochem"},{"key":"611_CR16","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1176\/appi.ajp.158.3.360","volume":"158","author":"S Kapur","year":"2001","unstructured":"Kapur S, Seeman P (2001) Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics?: a new hypothesis. Am J Psychiatry 158:360\u2013369","journal-title":"Am J Psychiatry"},{"key":"611_CR17","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1176\/ajp.156.2.286","volume":"156","author":"S Kapur","year":"1999","unstructured":"Kapur S, Zipursky RB, Remington G (1999) Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Am J Psychiatry 156:286\u2013293","journal-title":"Am J Psychiatry"},{"key":"611_CR18","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1176\/appi.ajp.157.4.514","volume":"157","author":"S Kapur","year":"2000","unstructured":"Kapur S, Zipursky R, Jones C, Remington G, Houle S (2000a) Relationship between dopamine D2 occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am J Psychiatry 157:514\u2013520","journal-title":"Am J Psychiatry"},{"issue":"6","key":"611_CR19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archpsyc.57.6.553","volume":"57","author":"S Kapur","year":"2000","unstructured":"Kapur S, Zipursky R, Jones C, Shammi CS, Remington G, Seeman P (2000b) A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy. Arch Gen Psychiatry 57(6):553\u2013559","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"611_CR20","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1176\/appi.ajp.159.5.761","volume":"159","author":"P Karlsson","year":"2002","unstructured":"Karlsson P, Farde L, Halldin C, Sedvall G (2002) PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia. Am J Psychiatry 159(5):761\u2013767","journal-title":"Am J Psychiatry"},{"issue":"2","key":"611_CR21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13(2):261\u2013276","journal-title":"Schizophr Bull"},{"issue":"Suppl 1","key":"611_CR22","first-page":"S38","volume":"68","author":"KU Kuehn","year":"2000","unstructured":"Kuehn KU, Meyer K, Maier W (2000) Flupentixol\u2014ein partiell atypisches Neuroleptikum? Fortschr Neurol Psychiatr 68(Suppl 1):S38\u2013S41","journal-title":"Fortschr Neurol Psychiatr"},{"key":"611_CR23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/nimg.1996.0066","volume":"4","author":"AA Lammertsma","year":"1996","unstructured":"Lammertsma AA, Hume SP (1996) Simplified reference tissue model for PET receptor studies. Neuroimage 4:153\u2013158","journal-title":"Neuroimage"},{"key":"611_CR24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00004647-200003000-00001","volume":"20","author":"M Laruelle","year":"2000","unstructured":"Laruelle M (2000) Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 20:423\u2013451","journal-title":"J Cereb Blood Flow Metab"},{"key":"611_CR25","first-page":"743","volume":"35","author":"M Laruelle","year":"1994","unstructured":"Laruelle M, van Dyck C, Abi-Dargham A, Zea-Ponce Y, Zoghbi SS, Charney DS, Baldwin RM, Hoffer PB, Kung HF, Innis RB (1994) Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjects. J Nucl Med 35:743\u2013754","journal-title":"J Nucl Med"},{"issue":"11","key":"611_CR26","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0006-3223(98)00187-5","volume":"44","author":"JA Lieberman","year":"1998","unstructured":"Lieberman JA, Mailman RB, Duncan G, Sikich L, Chakos M, Nichols DE, Kraus JE (1998) Serotonergic basis of antipsychotic drug effects in schizophrenia. Biol Psychiatry 44(11):1099\u20131117","journal-title":"Biol Psychiatry"},{"issue":"5","key":"611_CR27","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/00004647-199609000-00008","volume":"16","author":"J Logan","year":"1996","unstructured":"Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL (1996) Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16(5):834\u2013840","journal-title":"J Cereb Blood Flow Metab"},{"key":"611_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0925-4927(96)02653-4","volume":"67","author":"T Lundberg","year":"1996","unstructured":"Lundberg T, Lindstrom L, Hartvig P, Reibring L, Agren H et al (1996) Serotonin-2 and dopamine-1 binding components of clozapine in frontal and striatum in the brain visualized by positron emission tomography. Psychiatry Res 67:1\u201310","journal-title":"Psychiatry Res"},{"key":"611_CR29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1192\/S0007125000296876","volume":"17","author":"HY Meltzer","year":"1992","unstructured":"Meltzer HY (1992) The importance of serotonin\u2013dopamine interactions in the action of clozapine. Br J Psychiatry Suppl (17):22\u201329","journal-title":"Br J Psychiatry Suppl"},{"key":"611_CR30","first-page":"238","volume":"251","author":"HY Meltzer","year":"1989","unstructured":"Meltzer HY, Matsubara S, Lee JC (1989) Classification of typical and atypical antipsychotic drugs on the basis of dopamine D1, D2 and serotonin2 pKi values. J Pharmacol Exp Ther 251:238\u2013246","journal-title":"J Pharmacol Exp Ther"},{"key":"611_CR31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0006-3223(93)90288-O","volume":"33","author":"AL Nordstroem","year":"1993","unstructured":"Nordstroem AL, Farde L, Wiesel FA, Forslund K, Pauli S, Halldin C, Uppfeldt G (1993) Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET trial of schizophrenic patients. Biol Psychiatry 33:227\u2013235","journal-title":"Biol Psychiatry"},{"key":"611_CR32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF02251280","volume":"110","author":"S Nyberg","year":"1993","unstructured":"Nyberg S, Farde S, Eriksson L, Halldin C, Eriksson B (1993) 5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone. Psychopharmacology (Berl) 110:265\u2013272","journal-title":"Psychopharmacology (Berl)"},{"issue":"Suppl 3","key":"611_CR33","first-page":"81","volume":"10","author":"S Nyberg","year":"1995","unstructured":"Nyberg S, Nordstrom AL, Halldin C, Farde L (1995) Position emission tomography studies on D2 dopamine receptor occupancy and plasma antipsychotic drug levels in man. Int Clin Psychopharmacol 10(Suppl 3):81\u201385","journal-title":"Int Clin Psychopharmacol"},{"key":"611_CR34","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1192\/S0007125000298309","volume":"29","author":"S Nyberg","year":"1996","unstructured":"Nyberg S, Nakashima Y, Nordstrom AL, Halldin C, Farde L (1996) Positron emission tomography of in-vivo binding characteristics of atypical antipsychotic drugs. Review of D2 and 5-HT2 receptor occupancy studies and clinical response. Br J Psychiatry Suppl (29):40\u201344","journal-title":"Br J Psychiatry Suppl"},{"issue":"Suppl 3","key":"611_CR35","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1097\/00004850-199803003-00003","volume":"13","author":"S Nyberg","year":"1998","unstructured":"Nyberg S, Nilsson U, Okubo Y, Halldin C, Farde L (1998) Implications of brain imaging for the management of schizophrenia. Int Clin Psychopharmacol 13(Suppl 3):S15\u2013S20","journal-title":"Int Clin Psychopharmacol"},{"key":"611_CR36","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1176\/ajp.156.6.869","volume":"156","author":"S Nyberg","year":"1999","unstructured":"Nyberg S, Eriksson B, Oxenstierna G, Halldin C, Farde L (1999) Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients. Am J Psychiatry 156:869\u2013875","journal-title":"Am J Psychiatry"},{"issue":"25","key":"611_CR37","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/S0024-3205(00)80005-3","volume":"66","author":"Y Okubo","year":"2000","unstructured":"Okubo Y, Suhara T, Suzuki K, Kobayashi K, Inoue O, Terasaki O, Someya Y, Sassa T, Sudo Y, Matsushima E, Iyo M, Tateno Y, Toru M (2000) Serotonin 5-HT2 receptors in schizophrenic patients studied by positron emission tomography. Life Sci 66(25):2455\u20132464","journal-title":"Life Sci"},{"key":"611_CR38","first-page":"67","volume":"9","author":"M Philipp","year":"2002","unstructured":"Philipp M, Lesch OM, Walter H, Patras L, Kurtz G, Schmau\u00df M, Seemann U, Roth G, St\u00f6hr K, Dose M, Hetzel G, Ruhrmann S, Beneke M, Rappard F, Glaser T (2002) Wirksamkeit von Flupentixol vs Risperidon auf die Negativsymptomatik schizophrener Patienten. Psychopharmakotherapie 9:67\u201374","journal-title":"Psychopharmakotherapie"},{"issue":"Suppl 2","key":"611_CR39","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1055\/s-2003-39746","volume":"30","author":"M Philipp","year":"2003","unstructured":"Philipp M, Lesch OM, Schmauss M, Dose M, Glaser T (2003) Comparative effectiveness of flupenthixol and risperidone on negative symptoms of schizophrenia. Psychiatr Prax 30(Suppl 2):S94\u2013S96","journal-title":"Psychiatr Prax"},{"issue":"4","key":"611_CR40","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s00259-003-1389-5","volume":"31","author":"M Reimold","year":"2004","unstructured":"Reimold M, Mueller-Schauenburg W, Becker GA, Reischl G, Dohmen BM, Bares R (2004) Non-invasive assessment of distribution volume ratios and binding potential: tissue heterogeneity and interindividually averaged time\u2013activity curves. Eur J Nucl Med Mol Imaging 31(4):564\u2013577","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"611_CR41","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0006-3223(97)00442-3","volume":"43","author":"J Schr\u00f6der","year":"1998","unstructured":"Schr\u00f6der J, Silvestri S, Bubeck B, Karr M, Demisch S, Scherrer S, Geider FJ, Sauer H (1998) D2 dopamine receptor up-regulation, treatment response, neurological soft signs, and extrapyramidal side effects in schizophrenia: a follow-up study with 123I-iodobenzamide single photon emission computed tomography in the drug-naive state and after neuroleptic treatment. Biol Psychiatry 43(9):660\u2013665","journal-title":"Biol Psychiatry"},{"key":"611_CR42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/070674370204700106","volume":"47","author":"P Seeman","year":"2002","unstructured":"Seeman P (2002) Atypical antipsychotics: mechanism of action. Can J Psychiatry 47:27\u201338","journal-title":"Can J Psychiatry"},{"issue":"9","key":"611_CR43","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1176\/appi.ajp.161.9.1620","volume":"161","author":"J Tauscher","year":"2004","unstructured":"Tauscher J, Hussain T, Agid O, Verhoeff NP, Wilson AA, Houle S, Remington G, Zipursky RB, Kapur S (2004) Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics. Am J Psychiatry 161(9):1620\u20131625","journal-title":"Am J Psychiatry"},{"issue":"1","key":"611_CR44","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0022-3565(24)29327-7","volume":"299","author":"DM Weiner","year":"2001","unstructured":"Weiner DM, Burstein ES, Nash N, Croston GE, Currier EA, Vanover KE, Harvey SC, Donohue E, Hansen HC, Andersson CM, Spalding TA, Gibson DF, Krebs-Thomson K, Powell SB, Geyer MA, Hacksell U, Brann MR (2001) 5-hydroxytryptamine2A receptor inverse agonists as antipsychotics. J Pharmacol Exp Ther 299(1):268\u2013276","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-006-0611-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-006-0611-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-006-0611-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T23:31:17Z","timestamp":1736638277000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-006-0611-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,17]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,12,19]]}},"alternative-id":["611"],"URL":"https:\/\/doi.org\/10.1007\/s00213-006-0611-0","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,17]]}}}